A Case Report of a Modern-Day Scurvy
Abstract
51 A Case Report of a Modern-Day Scurvy Jared Regehr, M.D.1,2, Mariah Kriwiel, M.D.1,2, Emily Roth, M.D.3, Samuel Ofei-Dodoo, Ph.D., MPA, M.A.1,2 University of Kansas School of Medicine-Wichita, Wichita, KS 1Department of Family and Community Medicine 2Family Medicine Residency Program at Ascension Via Christi Hospital 3Ascension Via Christi St. Francis Hospital, Department of Emergency Medicine, Wichita, KS Received Sept. 2, 2020; Accepted for publication Oct. 27, 2020; Published online Feb. 12, 2021 https://doi.org/10.17161/kjm.vol1414609
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.